Article
Revolutionizing Personalized Medicine: How IRT Platforms are Transforming Cell and Gene Therapy Trials
Published on PharmaPhorum by Cara Woodruff, Director of Product Management, IQVIA IRT
May 07, 2025
Download

This article delves into the transformative impact of Interactive Response Technology (IRT) platforms on cell and gene therapy (CGT) trials. It highlights the unique logistical challenges of CGT trials, where each treatment is tailored to individual patients, requiring meticulous tracking and management throughout the supply chain. IRT platforms offer comprehensive solutions by adapting to specific trial requirements, ensuring precise tracking, temperature control, and real-time status monitoring.

The article emphasizes the importance of a consultative partnership approach between sponsors and technology providers to navigate the complexities of CGT trials successfully. It also discusses the critical role of data integrity and regulatory compliance in maintaining trial validity. As the field of gene therapy evolves, IRT platforms continue to innovate, supporting the advancement of personalized medicine and bringing revolutionary treatments to patients safely and efficiently.

Related solutions

Contact Us